Progressive(PGR)
Search documents
The Progressive Corporation (PGR) Hits Fresh High: Is There Still Room to Run?
ZACKS· 2024-08-16 14:17
Have you been paying attention to shares of Progressive (PGR) ? Shares have been on the move with the stock up 5.5% over the past month. The stock hit a new 52-week high of $238.45 in the previous session. Progressive has gained 48.7% since the start of the year compared to the 12.6% move for the Zacks Finance sector and the 22.4% return for the Zacks Insurance - Property and Casualty industry.What's Driving the Outperformance?The stock has a great record of positive earnings surprises, as it hasn't missed ...
Progressive (PGR) Up 5.9% Since Last Earnings Report: Can It Continue?
ZACKS· 2024-08-15 16:30
It has been about a month since the last earnings report for Progressive (PGR) . Shares have added about 5.9% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Progressive due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers. Progressive's Q2 Earnings Beat, Premiums Rise Y/ ...
Progressive Corporation(PGR.US)July 2024: PIF Better; underlying loss ratio below consensus
UBS· 2024-08-15 03:00
Investment Rating - The report assigns a 12-month rating of Neutral to Progressive Corporation [5][19]. Core Insights - The report indicates that Progressive Corporation (PGR) experienced better-than-expected growth in Personal Insurance Fund (PIF) in July, although the underlying loss ratio was slightly worse than consensus expectations [2][3]. - PGR's operating EPS for June was reported at $1.30, exceeding the forecast of $0.89, with a favorable prior year development (PYD) of $82.9 million [3][4]. - The agency PIF growth was up 1.8% month-over-month, while direct PIF growth was up 2.4% month-over-month, both surpassing expectations [4]. Summary by Sections Financial Performance - PGR's annualized loss ratio (AYLR) was reported at 66.3%, down 6.3 percentage points year-over-year and up 4 percentage points month-over-month, but below the UBS estimate of 70.1% [4]. - The expense ratio was relatively low at 0.7%, up 5.3 percentage points year-over-year and above the UBS estimate of 19.3% [4]. - Companywide net premium written (NPW) growth was reported at 7.2% year-over-year, significantly above the UBS estimate of 3.9% [4]. Market Position and Outlook - PGR is expected to continue gaining market share as it loosens underwriting restrictions faster than the industry, although growth may slow due to increasing competitive pressures [2]. - The report forecasts a price target of $233.00 for PGR, with a current price of $222.33 [5][19]. - The forecasted stock return is 6.1%, with a price appreciation of 4.8% and a dividend yield of 1.3% [8]. Company Overview - Progressive Corporation is one of the largest personal auto insurers in the US and the largest commercial auto insurer, distributing products through over 35,000 independent agents and direct channels [9].
S&P 500 Gains and Losses Today: Progressive, Schwab Boosted by Strong Monthly Updates
Investopedia· 2024-08-14 22:16
Key TakeawaysThe S&P 500 advanced 0.4% on Wednesday, Aug. 14, 2024, as the latest CPI data showed inflation ticked lower during July.Shares of Progressive and Charles Schwab moved higher after the insurer and financial services firm reported strong monthly results for July.Albemarle shares sank as diminished lithium prices remain an overhang on the largest producer of the metal. Major U.S. equities indexes ticked higher as the latest Consumer Price Index (CPI) data revealed that inflation cooled slightly mo ...
Progressive Reports July 2024 Results
GlobeNewswire News Room· 2024-08-14 12:31
MAYFIELD VILLAGE, OHIO, Aug. 14, 2024 (GLOBE NEWSWIRE) -- The Progressive Corporation (NYSE:PGR) today reported the following results for the month ended July 31, 2024: July(millions, except per share amounts and ratios; unaudited)2024Net premiums written$6,378.5Net premiums earned$6,066.1Net income$813.5Per share available to common shareholders$1.38Total pretax net realized gains (losses) on securities$62.2Combined ratio – current year 88.0 – prior year month 90.6Average diluted equival ...
Progressive Care Inc. Announces Second Quarter 2024 Revenues of $13.5 Million, an Increase of 17% as Gross Margin Expands to 35%
Prnewswire· 2024-08-14 11:30
41% Growth in 340B Contract Service Revenue and Momentum in Prescription Volumes Drive Positive Cashflow from OperationsMIAMI, Aug. 14, 2024 /PRNewswire/ -- Progressive Care Inc. (OTCQB: RXMD) ("Progressive Care" or the "Company"), a personalized healthcare services and technology provider, today announced financial results for its second quarter of 2024. The Company reported second quarter revenues of approximately $13.5 million, a 17% increase compared to revenues reported in the second quarter of 2023. R ...
Is Progressive (PGR) Still Worth Buying Post Q2 Earnings?
ZACKS· 2024-08-13 15:02
The Progressive Corporation (PGR) reported strong second-quarter 2024 results, wherein the top line and the bottom line beat the Zacks Consensus Estimate. Net premiums written increased 22%, driven by the strong performance of operating businesses. Combined ratio — the percentage of premiums paid out as claims and expenses — improved 850 basis points (bps) from the prior-year quarter’s level to 91.9.PGR is one of the country’s largest auto insurance groups, the largest seller of motorcycle and boat policies ...
Kyverna Therapeutics Receives U.S. FDA RMAT Designation for KYV-101 in the Treatment of Patients With Progressive Myasthenia Gravis
Prnewswire· 2024-08-12 20:05
The application was evaluated based on the positive clinical outcomes in patients treated in Germany under the named-patient programThe Regenerative Medicine Advanced Therapies designation allows Kyverna to leverage on more expedited meetings and more senior FDA leadership involvement throughout the development cycle for KYV-101EMERYVILLE, Calif., Aug. 12, 2024 /PRNewswire/ -- Kyverna Therapeutics, Inc. (Kyverna), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therap ...
Progressive(PGR) - 2024 Q2 - Earnings Call Transcript
2024-08-06 15:53
The Progressive Corporation (NYSE:PGR) Q2 2024 Earnings Conference Call August 6, 2024 9:30 AM ET Company Participants Doug Constantine - Director, Investor Relations Pat Callahan - President, Personal Lines Jay VanAntwerp - Media Business Leader Dave Krew - Acquisition Experience Team Tricia Griffith - President & Chief Executive Officer Conference Call Participants Bob Jian Huang - Morgan Stanley Elyse Greenspan - Wells Fargo Mike Phillips - Oppenheimer Gregory Peters - Raymond James Josh Shanker - Bank o ...
Progressive(PGR) - 2024 Q2 - Quarterly Report
2024-08-05 13:27
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2024 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number: 001-09518 THE PROGRESSIVE CORPORATION (Exact name of registrant as specified in its charter) Ohio 34-0963169 (State or other jurisdi ...